CoQ10 for liver fat in mitochondrial diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether taking coenzyme Q10 (a natural supplement) can reduce the amount of fat in the liver of people with a specific genetic form of diabetes (mitochondrial diabetes). It aims to see if the supplement can improve liver health and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have diabetes caused by a specific mitochondrial gene change (the m.3243A>G mutation).
- You must be between 18 and 70 years old.
- You must have other liver diseases (like viral hepatitis) or severe heart, lung, or kidney problems.
- You must be willing to take coenzyme Q10 (a supplement) and undergo liver fat measurements and MRI scans.
- You must not have used coenzyme Q10 or similar drugs in the past 3 months.
- You must be able to get an MRI scan safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.
This study tests whether Coenzyme Q10 (CoQ10) can help reduce fatigue and improve muscle strength in people who are taking GLP-1 medications for weight management. You will be asked to take a daily supplement (CoQ10 or placebo) for a period and track your progress via a smartphone app.
This study tests whether reducing liver fat can improve health in people with type 2 diabetes. It looks at the effects of a specific medication combined with exercise, tailored for those who are not very active.
This trial tests whether a supplement called CoQ10, along with supervised exercise, can improve how the body uses energy in people on chronic dialysis. It may help with muscle function and overall health if your heart and dialysis situation are stable enough.
This trial tests a new pill called QX1206 for people who have both Type 2 diabetes and fatty liver disease (NAFLD). The goal is to see if the medicine is safe and can help improve both conditions.
This study looks at how the liver uses energy (mitochondria) in people with type 2 diabetes and fatty liver disease. By understanding this, researchers may find better ways to treat liver problems.
Hear when a new Mitochondrial Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.